Characteristic of 523 COVID-19 in Henan Province and a Death Prediction Model
Related Experiment Video
Updated: Dec 6, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Xiaoxu Ma1, Ang Li2,3, Mengfan Jiao3
1Department of Respiration, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
A new COVID-19 death prediction model identifies older age and comorbidities as key risk factors. This model accurately predicts patient outcomes using clinical data, aiding in early intervention for coronavirus disease 2019 (COVID-19).
Area of Science:
- Infectious Diseases
- Epidemiology
- Medical Informatics
Background:
- Limited studies exist on predictive models for COVID-19 mortality.
- Identifying high-risk factors for COVID-19 death is crucial for patient management.
Purpose of the Study:
- To delineate clinical characteristics of COVID-19 patients across different severity levels.
- To establish and validate a predictive model for COVID-19 patient mortality.
Main Methods:
- Multi-centered, retrospective observational study of 523 COVID-19 cases.
- Screening for high-risk factors, model construction using random forest, and validation in diverse cohorts.
- Analysis included demographics, symptoms, and laboratory findings at admission.
Main Results:
- Non-survivors were older, had more comorbidities, and presented with delayed hospitalization.
- Key predictors for mortality included age, white blood cell count, D-dimer, and albumin levels.
- A mixed model incorporating multiple factors achieved an AUC of 0.9852, demonstrating high accuracy.
Conclusions:
- Age is a leading risk factor for poor prognosis in COVID-19 patients.
- A mixed predictive model combining clinical and laboratory data accurately predicts COVID-19 patient outcomes.
- The validated model offers a sensitive and specific tool for assessing mortality risk.
Abstract:
Certain high-risk factors related to the death of COVID-19 have been reported, however, there were few studies on a death prediction model. This study was conducted to delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) of different degree and establish a death prediction model. In this multi-centered, retrospective, observational study, we enrolled 523 COVID-19 cases discharged before February 20, 2020 in Henan Province, China, compared clinical data, screened for high-risk fatal factors, built a death prediction model and validated the model in 429 mild cases, six fatal cases discharged after February 16, 2020 from Henan and 14 cases from Wuhan. Out of the 523 cases, 429 were mild, 78 severe survivors, 16 non-survivors. The non-survivors with median age 71 were older and had more comorbidities than the mild and severe survivors. Non-survivors had a relatively delay in hospitalization, with higher white blood cell count, neutrophil percentage, D-dimer, LDH, BNP, and PCT levels and lower proportion of eosinophils, lymphocytes and albumin. Discriminative models were constructed by using random forest with 16 non-survivors and 78 severe survivors. Age was the leading risk factors for poor prognosis, with AUC of 0.907 (95% CI 0.831-0.983). Mixed model constructed with combination of age, demographics, symptoms, and laboratory findings at admission had better performance (p = 0.021) with a generalized AUC of 0.9852 (95% CI 0.961-1). We chose 0.441 as death prediction threshold (with 0.85 sensitivity and 0.987 specificity) and validated the model in 429 mild cases, six fatal cases discharged after February 16, 2020 from Henan and 14 cases from Wuhan successfully. Mixed model can accurately predict clinical outcomes of COVID-19 patients.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Steps in Outbreak Investigation

